Sureshkumar Pichakacheri

Consultant Diabetologist and head of research , Dr.Suresh’sDiabCare India
  • India

Beyond the Organs: Why “Fuel Toxicity-Associated Spectrum (FTAS)” Could Unite T2DM, MASLD, and MASH

If you work in metabolic research, you’ve felt the frustration. A patient presents with insulin resistance. A decade later, they develop non-alcoholic steatohepatitis (NASH). A colleague calls it “diabetic liver.” Another calls it “hepatic manifestation of metabolic syndrome.”